LLY compared with OPK: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

OPKOpko Health, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

OPKOpko Health, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

OPK: latest quarter is a loss; flow not drawable.Method ›

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,419.27

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

OPKOpko Health, Inc.

1.78▲+3.49%· post 1.65

ClosedNov 4 '26

Mkt cap$1.3BRevenue$65MQ3 FY26Revenue$607MFY25

Compare

ClosedNov 4 '26

LLYELI Lilly & Co

OPKOpko Health, Inc.

1,417.89▲+0.60%post 1,419.27

Price

1.78▲+3.49%post 1.65

$1.3T

Mkt cap

$1.3B

Q3 FY26$24.4B

Revenue

$65MQ3 FY26

FY25$65.2B

Revenue

$607MFY25

LLY1,417.89▲+0.60%vsOPK1.78▲+3.49%ClosedNov 4 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only OPK 4

PFEPfizercustomer

ENTXEntera Biocustomer

—Nicoyaunlistedcustomer

—Vfmcrp

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

customer

Price

rebased to 0%

LLY, solidOPK, dashed